PharmaNet was a global contract research organization providing clinical development services, including consulting, Phase I and bio-equivalency clinical studies, and Phase II–IV clinical development programs to pharmaceutical, biotechnology, generic drug and medical device companies worldwide. JLL sold PharmaNet to inVentiv Health.
![](https://www.jllpartners.com/wp-content/cache/thumb/6f/145ea0664b32c6f_595x744_notcrop_notrise.jpg)